G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in Israel. The company's products include Prizma, a multi-sensor device that measures vital signs and generate the health trend report; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiography data. It develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, the company offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. Further, it provides various accessories for its healthcare products. G Medical Innovations Holdings Ltd was incorporated in 2014 and is based in Rehovot, Israel.
Frequently asked questions
What sector does G Medical Innovations Holdings Ltd (GMVDF) operate in?
G Medical Innovations Holdings Ltd belongs to the Healthcare sector and operates in the Medical Devices industry.
What is G Medical Innovations Holdings Ltd (GMVDF) current stock price?
As of the latest data, G Medical Innovations Holdings Ltd stock price is $0.00, with a previous close of $0.00.
What is G Medical Innovations Holdings Ltd (GMVDF) current market capitalization?
G Medical Innovations Holdings Ltd market cap is approximately 3.35 thousand.
What is G Medical Innovations Holdings Ltd (GMVDF) Earnings Per Share (EPS)?
The trailing EPS is -$0.26.
Does G Medical Innovations Holdings Ltd (GMVDF) pay dividends?
No. G Medical Innovations Holdings Ltd does not pay a dividend.
What is G Medical Innovations Holdings Ltd (GMVDF) beta (volatility) score?
G Medical Innovations Holdings Ltd has a beta of 1507.048, indicating very high volatility compared to the market.
